Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-05 2:03 pm Sale | 2025-04-30 | 13G | Alterity Therapeutics Limited ATHE | JPMORGAN CHASE & CO JPM | 0 0.000% | -429,671,484 (Position Closed) | Filing |
| 2025-05-05 2:03 pm Sale | 2025-04-30 | 13G | Baker Hughes Company BKR | JPMORGAN CHASE & CO JPM | 0 0.000% | -92,496,774 (Position Closed) | Filing |
| 2025-05-05 2:03 pm Sale | 2025-04-30 | 13G | IBEX Limited IBEX | JPMORGAN CHASE & CO JPM | 0 0.000% | -680,799 (Position Closed) | Filing |
| 2025-05-05 2:03 pm Sale | 2025-04-30 | 13G | Keros Therapeutics, Inc. KROS | JPMORGAN CHASE & CO JPM | 0 0.000% | -2,587,146 (Position Closed) | Filing |
| 2025-05-05 2:03 pm Sale | 2025-04-30 | 13G | Seagate Technology Holdings plc STX | JPMORGAN CHASE & CO JPM | 0 0.000% | -18,897,740 (Position Closed) | Filing |
| 2025-05-02 09:59 am Purchase | 2025-03-31 | 13G | Alterity Therapeutics Limited ATHE | JPMORGAN CHASE & CO JPM | 429,671,484 6.300% | 429,671,484 (New Position) | Filing History |
| 2025-05-02 09:59 am Purchase | 2025-03-31 | 13G | Keros Therapeutics, Inc. KROS | JPMORGAN CHASE & CO JPM | 2,587,146 6.300% | 2,587,146 (New Position) | Filing History |
| 2025-04-29 12:53 pm Purchase | 2025-03-31 | 13G | IBEX Limited IBEX | JPMORGAN CHASE & CO JPM | 680,799 5.100% | 680,799 (New Position) | Filing History |
| 2025-04-29 12:53 pm Purchase | 2025-03-31 | 13G | McDonald's Corporation MCD | JPMORGAN CHASE & CO JPM | 35,931,728 5.000% | 35,931,728 (New Position) | Filing History |
| 2025-04-29 12:53 pm Purchase | 2025-03-31 | 13G | Oscar Health, Inc. OSCR | JPMORGAN CHASE & CO JPM | 13,810,923 6.400% | 13,810,923 (New Position) | Filing History |
| 2025-04-29 12:53 pm Purchase | 2025-03-31 | 13G | SBA Communications Corporation SBAC | JPMORGAN CHASE & CO JPM | 5,963,039 5.500% | 5,963,039 (New Position) | Filing History |
| 2025-04-29 12:53 pm Purchase | 2025-03-31 | 13G | Twilio Inc. TWLO | JPMORGAN CHASE & CO JPM | 9,581,572 6.200% | 9,581,572 (New Position) | Filing History |
| 2025-04-29 12:53 pm Purchase | 2025-03-31 | 13G | Vulcan Materials Company VMC | JPMORGAN CHASE & CO JPM | 6,771,833 5.100% | 6,771,833 (New Position) | Filing History |
| 2025-04-29 12:53 pm Purchase | 2025-03-31 | 13G | Yum China Holdings, Inc. YUMC | JPMORGAN CHASE & CO JPM | 23,460,080 6.200% | 23,460,080 (New Position) | Filing History |
| 2025-04-25 2:57 pm Sale | 2025-03-31 | 13G | Ameriprise Financial, Inc. AMP | JPMORGAN CHASE & CO JPM | 5,789,850 6.000% | -1,754,363 (-23.25%) | Filing History |
| 2025-04-25 2:57 pm Purchase | 2025-03-31 | 13G | Bristol-Myers Squibb Company BMY | JPMORGAN CHASE & CO JPM | 104,688,497 5.100% | 104,688,497 (New Position) | Filing History |
| 2025-04-25 2:57 pm Purchase | 2025-03-31 | 13G | Cartesian Therapeutics, Inc. RNAC | JPMORGAN CHASE & CO JPM | 1,675,636 6.100% | 1,675,636 (New Position) | Filing History |
| 2025-04-25 2:57 pm Purchase | 2025-03-31 | 13G | Eaton Corporation plc ETN | JPMORGAN CHASE & CO JPM | 21,208,613 5.400% | 2,466,002 (+13.16%) | Filing History |
| 2025-04-25 2:57 pm Purchase | 2025-03-31 | 13G | Flowco Holdings Inc. FLOC | JPMORGAN CHASE & CO JPM | 1,504,723 5.800% | 1,504,723 (New Position) | Filing History |
| 2025-04-25 2:57 pm Purchase | 2025-03-31 | 13G | Henry Schein, Inc. HSIC | JPMORGAN CHASE & CO JPM | 6,275,132 5.000% | 6,275,132 (New Position) | Filing History |